SL
CNMD icon

Salomon & Ludwin’s CONMED CNMD Stock Holding History

Salomon & Ludwin’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43K Buy
41
+30
+273% +$1.22K ﹤0.01% 1975
2025
Q4 		$461 Sell
11
-131
-92% -$5.7K ﹤0.01% 2092
2025
Q3 		$6.83K Buy
+142
New +$7.36K ﹤0.01% 1577

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Salomon & Ludwin's CNMD Position: Q1 2026 in Review

Salomon & Ludwin increased its CONMED (CNMD) stake by 273% in Q1 2026, buying an estimated $1.22K and bringing the position to 41 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Salomon & Ludwin first reported a position in CNMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.83K in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Salomon & Ludwin held 41 shares of CONMED worth $1.43K as of Q1 2026.
  • Salomon & Ludwin bought 30 CONMED shares in Q1 2026, an estimated $1.22K.
  • CONMED made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1975 holding.
  • Salomon & Ludwin first reported a position in CONMED in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's CONMED position peaked at $6.83K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.